Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Reksa Dana Indeks BNP Paribas IDX Growth30 ETF (XBIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hetzer Medical Indonesia Tbk. vs Reksa Dana Indeks BNP Paribas IDX Growth30 ETF — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume), while Reksa Dana Indeks BNP Paribas IDX Growth30 ETF trades at Rp600 (market cap 120M). The key difference: Hetzer Medical Indonesia Tbk. is far larger — about 1158.8× Reksa Dana Indeks BNP Paribas IDX Growth30 ETF's market cap. Which is the better fit depends on your goals.
| MEDS | XBIG | |
|---|---|---|
Market Cap | 139.06B | 120M |
Volume | 51.66M | — |
Lot | 516.62K | — |
Turnover | 4.44B | — |
Average Price | 85.97 | — |
Value | 4.44B | — |
Indicative Equilibrium Price | 86 | — |
Indicative Equilibrium Volume | 9.62K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
MEDS
View details →XBIG
View details →About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →
